SPOP and colorectal cancer: Suppression of ALDH2 also caused promotion of anti-PD-1 therapeutic efficacy in colorectal cancer mouse model, indicating that ALDH2 facilitates tumor progression and enhanced immune escape via regulation of SPOP-mediated degradation of PD-L1 (60).